Abstract
AbstractNovel phosphonate (XIII) demonstrates promising anti‐HIV‐1 activity in vitro, whilst new nucleoside analogue (XIV) displays moderate antiviral activity against human cytomegalovirus in MRC cells.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
